cookinglobi.blogg.se

Shareholders who have any questions or require any assistance with completing a proxy or voting instruction form or who do not have the required materials, may contact D.F. The Company encourages all shareholders of record, as of the record date August 9, 2021, who have not yet voted, to do so by Octoat 11:59 p.m. to assist management with obtaining adequate votes to achieve the required quorum of at least a majority of the outstanding shares of common stock. As set forth in the proxy statement, the Company has engaged a proxy solicitor, D.F. ET on Wednesday, Octoat the Company's corporate headquarters 9605 Medical Center Drive, Suite 270, Rockville, MD 20850 to allow additional time for the Company's shareholders to vote on the proposals set forth in the Company's definitive proxy statement filed with the United States Securities and Exchange Commission (the "S.E.C.") on August 16, 2021.ĭuring the current adjournment, the Company will continue to solicit votes from its shareholders with respect to the proposals set forth in the Company's proxy statement. The annual meeting of shareholders therefore had no quorum and the meeting was adjourned and will reconvene at 9:30 a.m.

Approximately 46.2% of the shares of the Company's common stock outstanding as of the record date were properly voted at the time of the annual meeting. There were fewer than a majority of shares entitled to vote present, either in person or by proxy at this meeting.

ET was convened and adjourned, without any business being conducted, due to lack of the required quorum.Ī quorum consists of a majority of the shares entitled to vote.

21, 2021 /PRNewswire/ - Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal ("GI") diseases in areas of high unmet need, today announced that the Company's annual meeting of shareholders, on September 21, 2021, at 9:30 a.m.